Dr. Christina GY has obtained her PhD from Monash University in 2012. In her PhD research project she explored candidate early predictors for diabetic nephropathy. Her hypothetical candidate early predictor for diabetic nephropathy risk is CYP2E1. In her post-doctoral projects she developed a targeted proteomic approach to quantitate CYP2E1 from human blood samples and assessed the applicability of this analytical method in clinical practice. Her research interests are early biomolecules in the development of metabolic syndromes, drug metabolizing enzymes and obesity. Dr. Christina’s research expertise skills are HPLC, LCMS-MS, Genomics (Microarray analysis using Genespring and Partek softwares), Proteomics, Metabolomics, Bioinformatics and animal experimental models and cell culture models. Currently she is a Senior Lecturer (Metabolic Medicine) at the School of Medicine, Monash University Malaysia in Kuala Lumpur Malaysia. She teaches Problem Based Learning (PBL), Histology, Physiology and Pharmacology into the MD and Bachelor of Pharmacy courses.